{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T06:34:54Z","timestamp":1772951694944,"version":"3.50.1"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","medical-hypotheses.com","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.mehy.2017.10.024","type":"journal-article","created":{"date-parts":[[2017,10,26]],"date-time":"2017-10-26T06:46:34Z","timestamp":1509000394000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Autoimmunity against a glycolytic enzyme as a possible cause for persistent symptoms in Lyme disease"],"prefix":"10.1016","volume":"110","author":[{"given":"Paolo","family":"Maccallini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7349-0296","authenticated-orcid":false,"given":"Serena","family":"Bonin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giusto","family":"Trevisan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2017.10.024_b0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-4362.1990.tb03745.x","article-title":"Lyme disease. A general survey","volume":"29","author":"Trevisan","year":"1990","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.mehy.2017.10.024_b0010","unstructured":"A. Mygland, U. Ljostad, V. Fingerle, et al., EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis, Eur J Neurol 17 (2010), pp. 8\u201316, e11\u201314."},{"key":"10.1016\/j.mehy.2017.10.024_b0015","doi-asserted-by":"crossref","first-page":"e443","DOI":"10.1016\/j.ijid.2013.01.008","article-title":"Development of a foundation for a case definition of post-treatment Lyme disease syndrome","volume":"17","author":"Aucott","year":"2013","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.mehy.2017.10.024_b0020","unstructured":"I.o. Medicine, Critical Needs and Gaps in Understanding Prevention, Amelioration, and Resolution of Lyme and Other Tick-Borne Diseases: The Short-Term and Long-Term Outcomes: Workshop Report, The National Academies Press, Washington, DC (2011)."},{"key":"10.1016\/j.mehy.2017.10.024_b0025","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.molimm.2007.04.017","article-title":"Human homologues of a Borrelia T cell epitope associated with antibiotic-refractory Lyme arthritis","volume":"45","author":"Drouin","year":"2008","journal-title":"Mol Immunol"},{"key":"10.1016\/j.mehy.2017.10.024_b0030","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/art.37732","article-title":"A novel human autoantigen, endothelial cell growth factor, is a target of T and B cell responses in patients with Lyme disease","volume":"65","author":"Drouin","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.mehy.2017.10.024_b0035","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1023\/A:1013815322485","volume":"21","author":"Sigal","year":"2001","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.mehy.2017.10.024_b0040","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1128\/IAI.63.10.4130-4137.1995","article-title":"Experimental immunization with Borrelia burgdorferi induces development of antibodies to gangliosides","volume":"63","author":"Garcia-Monco","year":"1995","journal-title":"Infect Immun"},{"key":"10.1016\/j.mehy.2017.10.024_b0045","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jneuroim.2004.10.014","article-title":"Antibodies against OspA epitopes of Borrelia burgdorferi cross-react with neural tissue","volume":"159","author":"Alaedini","year":"2005","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.mehy.2017.10.024_b0050","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.bbi.2010.03.002","article-title":"Anti-neural antibody reactivity in patients with a history of Lyme borreliosis and persistent symptoms","volume":"24","author":"Chandra","year":"2010","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.mehy.2017.10.024_b0055","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jneuroim.2012.10.011","article-title":"Increased IFNalpha activity and differential antibody response in patients with a history of Lyme disease and persistent cognitive deficits","volume":"255","author":"Jacek","year":"2013","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.mehy.2017.10.024_b0060","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1007\/PL00000910","article-title":"Multifunctional alpha-enolase: its role in diseases","volume":"58","author":"Pancholi","year":"2001","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.mehy.2017.10.024_b0065","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1080\/00015550310006815","article-title":"Detection of spirochaetal DNA simultaneously in skin biopsies, peripheral blood and urine from patients with erythema migrans","volume":"84","author":"Pauluzzi","year":"2004","journal-title":"Acta dermato-venereologica"},{"key":"10.1016\/j.mehy.2017.10.024_b0070","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1212\/WNL.59.2.227","article-title":"Anti-basal ganglia antibodies in acute and persistent Sydenham's chorea","volume":"59","author":"Church","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.mehy.2017.10.024_b0075","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jneuroim.2005.10.014","article-title":"Neuronal surface glycolytic enzymes are autoantigen targets in post-streptococcal autoimmune CNS disease","volume":"172","author":"Dale","year":"2006","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.mehy.2017.10.024_b0080","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0022-2836(70)90057-4","article-title":"A general method applicable to the search for similarities in the amino acid sequence of two proteins","volume":"48","author":"Needleman","year":"1970","journal-title":"J Mol Biol"},{"key":"10.1016\/j.mehy.2017.10.024_b0085","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/0022-2836(91)90193-A","article-title":"Amino acid substitution matrices from an information theoretic perspective","volume":"219","author":"Altschul","year":"1991","journal-title":"J Mol Biol"},{"key":"10.1016\/j.mehy.2017.10.024_b0090","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1073\/pnas.87.6.2264","article-title":"Methods for assessing the statistical significance of molecular sequence features by using general scoring schemes","volume":"87","author":"Karlin","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.mehy.2017.10.024_b0095","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1432-1033.1988.tb14465.x","article-title":"Complete amino acid sequence of the neurone-specific gamma isozyme of enolase (NSE) from human brain and comparison with the non-neuronal alpha form (NNE)","volume":"178","author":"McAleese","year":"1988","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.mehy.2017.10.024_b0100","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/nchembio.2195","article-title":"SF2312 is a natural phosphonate inhibitor of enolase","volume":"12","author":"Leonard","year":"2016","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.mehy.2017.10.024_b0105","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nrg.2015.18","article-title":"Causes of evolutionary rate variation among protein sites","volume":"17","author":"Echave","year":"2016","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.mehy.2017.10.024_b0110","unstructured":"M. Vollmar, Krysztofinska, E., Chaikuad, A., Krojer, T., Cocking, R., Von Delft, F., Bountra, C., Arrowsmith, C.H., Weigelt, J., Edwards, A., Yue, W.W., Oppermann, U., Crystal Structure of Human Beta Enolase Enob, RCSB PDB (To Be Published)."},{"key":"10.1016\/j.mehy.2017.10.024_b0115","unstructured":"M. Institute of, Beyond Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome: Redefining an Illness%@ 978-0-309-31689-7, The National Academies Press, Washington, DC (2015)."},{"key":"10.1016\/j.mehy.2017.10.024_b0120","first-page":"101","article-title":"Dermatological manifestations of Lyme borrelosis","volume":"5","author":"Trevisan","year":"1996","journal-title":"Acta Dermatovenerologica Alpina, Pannonica et Adriatica"},{"key":"10.1016\/j.mehy.2017.10.024_b0125","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1001\/archgenpsychiatry.2009.29","article-title":"Regional cerebral blood flow and metabolic rate in persistent Lyme encephalopathy","volume":"66","author":"Fallon","year":"2009","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.mehy.2017.10.024_b0130","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/00006231-200208000-00011","article-title":"Cerebral metabolic changes associated with Lyme disease","volume":"23","author":"Newberg","year":"2002","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.mehy.2017.10.024_b0135","doi-asserted-by":"crossref","first-page":"507","DOI":"10.18388\/abp.2005_3466","article-title":"Molecular evolution of enolase","volume":"52","author":"Piast","year":"2005","journal-title":"Acta Biochim Pol"},{"key":"10.1016\/j.mehy.2017.10.024_b0140","doi-asserted-by":"crossref","first-page":"e27502","DOI":"10.1371\/journal.pone.0027502","article-title":"Borrelia burgdorferi enolase is a surface-exposed plasminogen binding protein","volume":"6","author":"Floden","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.mehy.2017.10.024_b0145","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1128\/IAI.05671-11","article-title":"A surface enolase participates in Borrelia burgdorferi-plasminogen interaction and contributes to pathogen survival within feeding ticks","volume":"80","author":"Nogueira","year":"2012","journal-title":"Infect Immun"},{"key":"10.1016\/j.mehy.2017.10.024_b0150","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1128\/IAI.05836-11","article-title":"The enolase of Borrelia burgdorferi is a plasminogen receptor released in outer membrane vesicles","volume":"80","author":"Toledo","year":"2012","journal-title":"Infect Immun"},{"key":"10.1016\/j.mehy.2017.10.024_b0155","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1128\/IAI.00048-08","article-title":"A genome-wide proteome array reveals a limited set of immunogens in natural infections of humans and white-footed mice with Borrelia burgdorferi","volume":"76","author":"Barbour","year":"2008","journal-title":"Infect Immun"},{"key":"10.1016\/j.mehy.2017.10.024_b0160","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/j.1460-2075.1986.tb04226.x","article-title":"Location of 'continuous' antigenic determinants in the protruding regions of proteins","volume":"5","author":"Thornton","year":"1986","journal-title":"EMBO J"},{"key":"10.1016\/j.mehy.2017.10.024_b0165","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1110\/ps.062405906","article-title":"Prediction of residues in discontinuous B-cell epitopes using protein 3D structures","volume":"15","author":"Haste Andersen","year":"2006","journal-title":"Protein Sci"},{"key":"10.1016\/j.mehy.2017.10.024_b0170","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/brain\/awh008","article-title":"Encephalitis lethargica syndrome: 20 new cases and evidence of basal ganglia autoimmunity","volume":"127","author":"Dale","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.mehy.2017.10.024_b0175","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1192\/bjp.bp.111.092007","article-title":"Prevalence of anti-basal ganglia antibodies in adult obsessive-compulsive disorder: cross-sectional study","volume":"200","author":"Nicholson","year":"2012","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.mehy.2017.10.024_b0180","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1136\/adc.2003.031880","article-title":"Anti-basal ganglia antibodies: a possible diagnostic utility in idiopathic movement disorders?","volume":"89","author":"Church","year":"2004","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.mehy.2017.10.024_b0185","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.bbacli.2015.08.001","article-title":"No evidence of antibodies against GAD65 and other specific antigens in children with autism","volume":"4","author":"Kalra","year":"2015","journal-title":"BBA Clin"},{"key":"10.1016\/j.mehy.2017.10.024_b0190","first-page":"35","article-title":"Detection of anti-streptococcal, antienolase, and anti-neural antibodies in subjects with early-onset psychiatric disorders","volume":"43","author":"Nicolini","year":"2015","journal-title":"Actas Esp Psiquiatr"},{"key":"10.1016\/j.mehy.2017.10.024_b0195","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1192\/bjp.187.4.314","article-title":"Incidence of anti-brain antibodies in children with obsessive-compulsive disorder","volume":"187","author":"Dale","year":"2005","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.mehy.2017.10.024_b0200","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/s00417-006-0527-8","article-title":"Enolase autoantibodies and retinal function in multiple sclerosis patients","volume":"245","author":"Forooghian","year":"2007","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.mehy.2017.10.024_b0205","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jneuroim.2005.02.004","article-title":"Autoantibodies against the amino terminal of alpha-enolase are a useful diagnostic marker of Hashimoto's encephalopathy","volume":"162","author":"Fujii","year":"2005","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.mehy.2017.10.024_b0210","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0014-5793(02)03307-0","article-title":"Proteomic analysis of human brain identifies alpha-enolase as a novel autoantigen in Hashimoto's encephalopathy","volume":"528","author":"Ochi","year":"2002","journal-title":"FEBS Lett"},{"key":"10.1016\/j.mehy.2017.10.024_b0215","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jneuroim.2007.01.018","article-title":"High prevalence of serum autoantibodies against the amino terminal of alpha-enolase in Hashimoto's encephalopathy","volume":"185","author":"Yoneda","year":"2007","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.mehy.2017.10.024_b0220","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1086\/317604","article-title":"Antibodies to streptococcal surface enolase react with human alpha-enolase: implications in poststreptococcal sequelae","volume":"182","author":"Fontan","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.mehy.2017.10.024_b0225","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1002\/art.11074","article-title":"Human alpha-enolase from endothelial cells as a target antigen of anti-endothelial cell antibody in Behcet's disease","volume":"48","author":"Lee","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.mehy.2017.10.024_b0230","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.autrev.2006.10.004","article-title":"Alpha-enolase: a target of antibodies in infectious and autoimmune diseases","volume":"6","author":"Terrier","year":"2007","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.mehy.2017.10.024_b0235","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1006\/jaut.1998.0239","article-title":"Anti-enolase-alpha autoantibodies in cancer-associated retinopathy: epitope mapping and cytotoxicity on retinal cells","volume":"11","author":"Adamus","year":"1998","journal-title":"J Autoimmun"},{"key":"10.1016\/j.mehy.2017.10.024_b0240","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S0896-8411(95)80027-1","article-title":"Autoreactive epitopes within the human alpha-enolase and their recognition by sera from patients with endometriosis","volume":"8","author":"Walter","year":"1995","journal-title":"J Autoimmun"},{"key":"10.1016\/j.mehy.2017.10.024_b0245","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000324292","article-title":"Gamma-1-syntrophin mediates trafficking of gamma-enolase towards the plasma membrane and enhances its neurotrophic activity","volume":"18","author":"Hafner","year":"2010","journal-title":"Neurosignals"},{"key":"10.1016\/j.mehy.2017.10.024_b0250","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10875-006-9065-8","article-title":"The role of anti-alpha-enolase autoantibodies in pathogenicity of autoimmune-mediated retinopathy","volume":"27","author":"Magrys","year":"2007","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.mehy.2017.10.024_b0255","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0141-8130(91)90055-Y","article-title":"Mapping of isozymic differences in enolase","volume":"13","author":"Lebioda","year":"1991","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.mehy.2017.10.024_b0260","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/nri2529","article-title":"Losing your nerves? Maybe it's the antibodies","volume":"9","author":"Diamond","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.mehy.2017.10.024_b0265","first-page":"1392","article-title":"Clinical and neurocognitive features of the post Lyme syndrome","volume":"23","author":"Bujak","year":"1996","journal-title":"J Rheumatol"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987717307715?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987717307715?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T14:02:29Z","timestamp":1603202549000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987717307715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":53,"alternative-id":["S0306987717307715"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2017.10.024","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmunity against a glycolytic enzyme as a possible cause for persistent symptoms in Lyme disease","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2017.10.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}